Irene Zahirovic, PhD
Associate Director, Value Communications
Expertise:
Irene has extensive experience in clinical research, medical writing, and development of promotional and educational medical content for various audiences, including healthcare providers, patients, regulatory authorities, and payers. Areas of specialization at EVERSANA include development of value dossiers (GVDs, AMCP dossiers), value briefs, structured and systematic literature reviews, clinical summaries, and other value communication materials. Irene has experience across a variety of therapeutic areas, including oncology, ophthalmology, immunology and rare diseases. She holds a PhD degree in Pharmacology and Biomedical Toxicology from the University of Toronto, where she also served as an assistant professor of clinical pharmacology.
Articles by Irene Zahirovic, PhD
The New AMCP Dossier Format Version 5.0: Key Implications for Strategic Approach
The Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions is the industry standard for communicating clinical and economic information to meet the evidentiary requirements/needs of healthcare decision-makers (HCDMs) in the United States. The latest updates to the AMCP Format (version 5.0, published March 31, 2024) have added guidance on health disparities, real-world evidence (RWE), digital therapeutics, preapproval information exchange (PIE) and the need for brevity in medical communications. Health Disparities AMCP Format 5.0 provides guidance on incorporating information on health disparities related to social and demographic factors, as well as recommendations related to evaluations of pharmacoequity. Unique search strategies may now be needed to capture relevant information on […]